Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- 31 October 2010
- journal article
- review article
- Published by Elsevier BV in Drug Resistance Updates
- Vol. 13 (4-5), 109-118
- https://doi.org/10.1016/j.drup.2010.07.001
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- CD44‐positive cells are responsible for gemcitabine resistance in pancreatic cancer cellsInternational Journal of Cancer, 2009
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem CellsCell, 2009
- Emerging role of Notch in stem cells and cancerCancer Letters, 2009
- miR-200 Regulates PDGF-D-Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer CellsThe International Journal of Cell Cloning, 2009
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cellsHepatology, 2009
- The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer TherapiesJournal of Mammary Gland Biology and Neoplasia, 2009
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cellsBiochemical Pharmacology, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cellsInternational Journal of Cancer, 2008
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerationsDrug Resistance Updates, 2008